Polymorphic N-acetylation of a caffeine metabolite
- 1 March 1983
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 33 (3) , 355-359
- https://doi.org/10.1038/clpt.1983.45
Abstract
In the course of investigations into variability in the metabolism of caffeine [a central stimulant] in human populations, urinary levels of 5-acetylamino-6-formylamino-3-methyluracil (AFMU), a newly discovered ring-opened metabolite of caffeine, were both bimodally distributed and interethnically variable in samples (Caucasian: n = 42; Oriental: n = 26) from the Toronto population. To test the premise that the polymorphic N-acetyltransferase enzyme (EC 2.3.1.-) could be responsible for the production of AFMU, 20 of the subjects were phenotyped for acetylator status using sulfamethazine (SMZ). Concordance for all subjects between AFMU production and SMZ acetylation strongly suggests that the acetylation polymorphism is involved in the formation of AFMU in man.This publication has 6 references indexed in Scilit:
- Caffeine disposition after oral dosesClinical Pharmacology & Therapeutics, 1982
- Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath testEuropean Journal of Clinical Pharmacology, 1981
- Metabolic pathway of theobromine in the rat and identification of two new metabolites in human urineJournal of Agricultural and Food Chemistry, 1979
- Caffeine metabolism in the newbornClinical Pharmacology & Therapeutics, 1979
- Efficacy of caffeine in treatment of apnea in the low-birth-weight infantThe Journal of Pediatrics, 1977
- Identification, kinetic and quantitative study of [2-14C] and [1-Me-14C]caffeine metabolites in rat's urine by chromatographic separationsBiochemical Medicine, 1976